BAINCO INTERNATIONAL INVESTORS - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 164 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
BAINCO INTERNATIONAL INVESTORS ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$3,858,000
-6.6%
152,839
+39.5%
0.44%
-15.8%
Q3 2020$4,132,000
+30.8%
109,550
+48.5%
0.52%
+17.2%
Q2 2020$3,160,000
+114.2%
73,794
-2.7%
0.45%
+73.6%
Q1 2020$1,475,000
-26.0%
75,850
-1.0%
0.26%
-9.2%
Q4 2019$1,992,000
-79.5%
76,650
-78.5%
0.28%
-81.1%
Q3 2019$9,700,000
+1.5%
355,9130.0%1.50%
-0.5%
Q2 2019$9,556,000
-6.5%
355,913
+0.7%
1.51%
-9.3%
Q1 2019$10,217,000353,4131.66%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$5,700,1778.82%
Wildcat Capital Management, LLC 1,920,787$6,088,8952.44%
TPG GP A, LLC 18,716,306$59,330,6901.02%
EcoR1 Capital, LLC 4,488,200$14,227,5940.48%
CROSSPOINT FINANCIAL, LLC 12,000$38,0400.40%
Coastal Bridge Advisors, LLC 406,847$1,289,7050.35%
CAXTON ASSOCIATES LP 480,104$1,521,9300.21%
Woodline Partners LP 5,313,915$16,845,1110.20%
Rhenman & Partners Asset Management AB 300,000$951,0000.10%
Navalign, LLC 75,365$238,9070.09%
View complete list of ALLOGENE THERAPEUTICS INC shareholders